Report Detail

Pharma & Healthcare Global Lurasidone Market Research Report 2021

  • RnM4286232
  • |
  • 16 February, 2021
  • |
  • Global
  • |
  • 90 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Lurasidone Market Overview

  • 1.1 Product Overview and Scope of Lurasidone
  • 1.2 Lurasidone Segment by Type
    • 1.2.1 Global Lurasidone Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 20mg/tablet
    • 1.2.3 40mg/tablet
    • 1.2.4 60mg/tablet
    • 1.2.5 80mg/tablet
    • 1.2.6 120mg/tablet
  • 1.3 Lurasidone Segment by Application
    • 1.3.1 Global Lurasidone Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Psychological Clinic
    • 1.3.4 Others
  • 1.4 Global Lurasidone Market Size Estimates and Forecasts
    • 1.4.1 Global Lurasidone Revenue 2016-2027
    • 1.4.2 Global Lurasidone Sales 2016-2027
    • 1.4.3 Lurasidone Market Size by Region: 2016 Versus 2021 Versus 2027

2 Lurasidone Market Competition by Manufacturers

  • 2.1 Global Lurasidone Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Lurasidone Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Lurasidone Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Lurasidone Manufacturing Sites, Area Served, Product Type
  • 2.5 Lurasidone Market Competitive Situation and Trends
    • 2.5.1 Lurasidone Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Lurasidone Players Market Share by Revenue
    • 2.5.3 Global Lurasidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Lurasidone Retrospective Market Scenario by Region

  • 3.1 Global Lurasidone Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Lurasidone Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Lurasidone Market Facts & Figures by Country
    • 3.3.1 North America Lurasidone Sales by Country
    • 3.3.2 North America Lurasidone Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Lurasidone Market Facts & Figures by Country
    • 3.4.1 Europe Lurasidone Sales by Country
    • 3.4.2 Europe Lurasidone Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Lurasidone Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Lurasidone Sales by Region
    • 3.5.2 Asia Pacific Lurasidone Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Lurasidone Market Facts & Figures by Country
    • 3.6.1 Latin America Lurasidone Sales by Country
    • 3.6.2 Latin America Lurasidone Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Lurasidone Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Lurasidone Sales by Country
    • 3.7.2 Middle East and Africa Lurasidone Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Lurasidone Historic Market Analysis by Type

  • 4.1 Global Lurasidone Sales Market Share by Type (2016-2021)
  • 4.2 Global Lurasidone Revenue Market Share by Type (2016-2021)
  • 4.3 Global Lurasidone Price by Type (2016-2021)

5 Global Lurasidone Historic Market Analysis by Application

  • 5.1 Global Lurasidone Sales Market Share by Application (2016-2021)
  • 5.2 Global Lurasidone Revenue Market Share by Application (2016-2021)
  • 5.3 Global Lurasidone Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Angelini Holding S.p.A.
    • 6.1.1 Angelini Holding S.p.A. Corporation Information
    • 6.1.2 Angelini Holding S.p.A. Description and Business Overview
    • 6.1.3 Angelini Holding S.p.A. Lurasidone Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Angelini Holding S.p.A. Lurasidone Product Portfolio
    • 6.1.5 Angelini Holding S.p.A. Recent Developments/Updates
  • 6.2 Sumitomo Dainippon Pharma Co., Ltd.
    • 6.2.1 Sumitomo Dainippon Pharma Co., Ltd. Corporation Information
    • 6.2.2 Sumitomo Dainippon Pharma Co., Ltd. Description and Business Overview
    • 6.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolio
    • 6.2.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments/Updates
  • 6.3 RemedyRepack,Inc.
    • 6.3.1 RemedyRepack,Inc. Corporation Information
    • 6.3.2 RemedyRepack,Inc. Description and Business Overview
    • 6.3.3 RemedyRepack,Inc. Lurasidone Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 RemedyRepack,Inc. Lurasidone Product Portfolio
    • 6.3.5 RemedyRepack,Inc. Recent Developments/Updates
  • 6.4 Bushu Pharmaceutical, LTD.
    • 6.4.1 Bushu Pharmaceutical, LTD. Corporation Information
    • 6.4.2 Bushu Pharmaceutical, LTD. Description and Business Overview
    • 6.4.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Bushu Pharmaceutical, LTD. Lurasidone Product Portfolio
    • 6.4.5 Bushu Pharmaceutical, LTD. Recent Developments/Updates
  • 6.5 Zhejiang Hisun Pharmaceutical Co., Ltd.
    • 6.5.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Corporation Information
    • 6.5.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Business Overview
    • 6.5.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolio
    • 6.5.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 6.6 Healthcare Pharmaceuticals Limited
    • 6.6.1 Healthcare Pharmaceuticals Limited Corporation Information
    • 6.6.2 Healthcare Pharmaceuticals Limited Description and Business Overview
    • 6.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Healthcare Pharmaceuticals Limited Lurasidone Product Portfolio
    • 6.6.5 Healthcare Pharmaceuticals Limited Recent Developments/Updates
  • 6.7 Square Pharmaceuticals Ltd.
    • 6.6.1 Square Pharmaceuticals Ltd. Corporation Information
    • 6.6.2 Square Pharmaceuticals Ltd. Description and Business Overview
    • 6.6.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Square Pharmaceuticals Ltd. Lurasidone Product Portfolio
    • 6.7.5 Square Pharmaceuticals Ltd. Recent Developments/Updates
  • 6.8 Incepta Pharmaceuticals Ltd.
    • 6.8.1 Incepta Pharmaceuticals Ltd. Corporation Information
    • 6.8.2 Incepta Pharmaceuticals Ltd. Description and Business Overview
    • 6.8.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolio
    • 6.8.5 Incepta Pharmaceuticals Ltd. Recent Developments/Updates

7 Lurasidone Manufacturing Cost Analysis

  • 7.1 Lurasidone Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Lurasidone
  • 7.4 Lurasidone Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Lurasidone Distributors List
  • 8.3 Lurasidone Customers

9 Lurasidone Market Dynamics

  • 9.1 Lurasidone Industry Trends
  • 9.2 Lurasidone Growth Drivers
  • 9.3 Lurasidone Market Challenges
  • 9.4 Lurasidone Market Restraints

10 Global Market Forecast

  • 10.1 Lurasidone Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Lurasidone by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Lurasidone by Type (2022-2027)
  • 10.2 Lurasidone Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Lurasidone by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Lurasidone by Application (2022-2027)
  • 10.3 Lurasidone Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Lurasidone by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Lurasidone by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    20mg/tablet
    40mg/tablet
    60mg/tablet
    80mg/tablet
    120mg/tablet

    Segment by Application
    Hospital
    Psychological Clinic
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Angelini Holding S.p.A.
    Sumitomo Dainippon Pharma Co., Ltd.
    RemedyRepack,Inc.
    Bushu Pharmaceutical, LTD.
    Zhejiang Hisun Pharmaceutical Co., Ltd.
    Healthcare Pharmaceuticals Limited
    Square Pharmaceuticals Ltd.
    Incepta Pharmaceuticals Ltd.


    Summary:
    Get latest Market Research Reports on Lurasidone. Industry analysis & Market Report on Lurasidone is a syndicated market report, published as Global Lurasidone Market Research Report 2021. It is complete Research Study and Industry Analysis of Lurasidone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,078.32
    3,117.48
    4,156.64
    2,402.44
    3,603.67
    4,804.89
    309,888.20
    464,832.30
    619,776.40
    212,911.62
    319,367.43
    425,823.24
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report